Cargando…
Antigen Loss Variants: Catching Hold of Escaping Foes
Since mid-1990s, the field of cancer immunotherapy has seen steady growth and selected immunotherapies are now a routine and preferred therapeutic option of certain malignancies. Both active and passive cancer immunotherapies exploit the fact that tumor cells express specific antigens on the cell su...
Autores principales: | Vyas, Maulik, Müller, Rolf, Pogge von Strandmann, Elke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323381/ https://www.ncbi.nlm.nih.gov/pubmed/28286501 http://dx.doi.org/10.3389/fimmu.2017.00175 |
Ejemplares similares
-
Cancer-derived extracellular vesicles: friend and foe of tumour immunosurveillance
por: Dörsam, Bastian, et al.
Publicado: (2018) -
Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset
por: Kloess, Stephan, et al.
Publicado: (2017) -
Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset
por: Kloess, Stephan, et al.
Publicado: (2018) -
Role of Exosomes Released by Dendritic Cells and/or by Tumor Targets: Regulation of NK Cell Plasticity
por: Reiners, Katrin S., et al.
Publicado: (2014) -
Soluble NKG2D ligands in the ovarian cancer microenvironment are associated with an adverse clinical outcome and decreased memory effector T cells independent of NKG2D downregulation
por: Vyas, Maulik, et al.
Publicado: (2017)